BIOMAT Database Logo BIOMAT Database Logo

Salvage stereotactic radiosurgery for recurrent gliomas with prior radiation therapy. 2017

Philip A Sutera, and Mark E Bernard, and Beant S Gill, and Kimmen Quan, and Johnathan A Engh, and Steven A Burton, and Dwight E Heron
Department of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA.

This study aims to assess the viability of salvage stereotactic radiosurgery (SRS) for recurrent malignant gliomas through assessing overall survival, local control and toxicity. We performed a retrospective review of 65 patients with 76 lesions (55 high-grade, 21 low-grade) treated with salvage SRS between 2002 and   2012. Median follow-up from salvage SRS was 14.9 months (IQR: 0.9-28.1), 8.3 months (IQR: 4.0-13.3) and 8.5 months (IQR: 3.9-15.8) for low-grade, high-grade, and combined, respectively. A 12-month overall survival from salvage SRS was 68.4, 38.7 and 47.3% for low-grade, high-grade and combined respectively. A total of 6-month local control was 86.2, 53.8 and 65.3% for low-grade, high-grade and combined, respectively. Our results indicate salvage SRS can provide acceptable survival and local control with minimal toxicity.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D005260 Female Females
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Philip A Sutera, and Mark E Bernard, and Beant S Gill, and Kimmen Quan, and Johnathan A Engh, and Steven A Burton, and Dwight E Heron
Salvage stereotactic radiosurgery for recurrent glioblastoma multiforme with prior radiation therapy.
January 2016, Journal of cancer research and therapeutics,
Philip A Sutera, and Mark E Bernard, and Beant S Gill, and Kimmen Quan, and Johnathan A Engh, and Steven A Burton, and Dwight E Heron
Stereotactic radiosurgery for recurrent gliomas.
August 1994, Cancer,
Philip A Sutera, and Mark E Bernard, and Beant S Gill, and Kimmen Quan, and Johnathan A Engh, and Steven A Burton, and Dwight E Heron
Salvage Leksell Stereotactic Radiosurgery for Malignant Gliomas.
January 2019, Progress in neurological surgery,
Philip A Sutera, and Mark E Bernard, and Beant S Gill, and Kimmen Quan, and Johnathan A Engh, and Steven A Burton, and Dwight E Heron
Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas.
May 2008, Cancer,
Philip A Sutera, and Mark E Bernard, and Beant S Gill, and Kimmen Quan, and Johnathan A Engh, and Steven A Burton, and Dwight E Heron
Stereotactic radiosurgery for recurrent malignant gliomas.
July 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Philip A Sutera, and Mark E Bernard, and Beant S Gill, and Kimmen Quan, and Johnathan A Engh, and Steven A Burton, and Dwight E Heron
Surgical salvage of recurrent vestibular schwannoma following prior stereotactic radiosurgery.
November 2016, The Laryngoscope,
Philip A Sutera, and Mark E Bernard, and Beant S Gill, and Kimmen Quan, and Johnathan A Engh, and Steven A Burton, and Dwight E Heron
Stereotactic radiosurgery for recurrent high-grade gliomas.
November 2014, World neurosurgery,
Philip A Sutera, and Mark E Bernard, and Beant S Gill, and Kimmen Quan, and Johnathan A Engh, and Steven A Burton, and Dwight E Heron
Salvage radiosurgery for selected patients with recurrent malignant gliomas.
January 2014, BioMed research international,
Philip A Sutera, and Mark E Bernard, and Beant S Gill, and Kimmen Quan, and Johnathan A Engh, and Steven A Burton, and Dwight E Heron
(S049) salvage stereotactic radiosurgery for locally recurrent brain metastases treated previously with stereotactic radiosurgery.
April 2015, Oncology (Williston Park, N.Y.),
Philip A Sutera, and Mark E Bernard, and Beant S Gill, and Kimmen Quan, and Johnathan A Engh, and Steven A Burton, and Dwight E Heron
Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
July 2017, Journal of neurosurgery,
Copied contents to your clipboard!